BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6752683)

  • 1. [Search for and development of antileishmaniasis preparations (a review of the literature)].
    Chistiakov DA; Drabkina AA; Rusak LV
    Med Parazitol (Mosk); 1982; 51(4):57-63. PubMed ID: 6752683
    [No Abstract]   [Full Text] [Related]  

  • 2. The fitness of antimony-resistant Leishmania parasites: lessons from the field.
    Ait-Oudhia K; Gazanion E; Oury B; Vergnes B; Sereno D
    Trends Parasitol; 2011 Apr; 27(4):141-2. PubMed ID: 21216196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of leishmaniasis. Recent studies].
    Magaudda PL; Pennisi L
    G Ital Chemioter; 1978; 25(2):97-106. PubMed ID: 755795
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial peptides for leishmaniasis.
    Cobb SL; Denny PW
    Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmaniasis activity of flavonoids from Consolida oliveriana.
    Marín C; Boutaleb-Charki S; Díaz JG; Huertas O; Rosales MJ; Pérez-Cordon G; Guitierrez-Sánchez R; Sánchez-Moreno M
    J Nat Prod; 2009 Jun; 72(6):1069-74. PubMed ID: 19489596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of paromomycin-I against Leishmania garnhami in heterozygote albino mice].
    Rezzano de Raffo S; Moreno G; García J; Scorza JV
    Rev Cubana Med Trop; 1985; 37(1):55-65. PubMed ID: 3915382
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of cutaneous leishmaniasis in Saudi Arabia.
    Fattah AA; Morsy TA; Ismail MA
    J Egypt Soc Parasitol; 1983 Jun; 13(1):9-17. PubMed ID: 6313824
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of some protozoan infections (leishmaniasis, trichomoniasis, lambliosis, toxoplasmosis). (Review)].
    Pershin GN
    Farmakol Toksikol; 1969; 32(3):342-56. PubMed ID: 4897615
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-leishmanial drug discovery: rising to the challenges of a highly neglected disease.
    Sharlow ER; Grögl M; Johnson J; Lazo JS
    Mol Interv; 2010 Apr; 10(2):72-5. PubMed ID: 20368366
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapeutic effectiveness of stibomen in experimental leishmaniasis and trypanosomiasis].
    Pershin GN; Moskalenko NIu
    Med Parazitol (Mosk); 1967; 36(4):422-7. PubMed ID: 5612807
    [No Abstract]   [Full Text] [Related]  

  • 11. The leishmaniases.
    Steck EA
    Prog Drug Res; 1974; 18():289-351. PubMed ID: 4453608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of cutaneous leishmaniasis of acutely necrotizing type with solusurmine].
    Dobrzhanskaia RS
    Vestn Dermatol Venerol; 1966 Oct; 40(10):57-61. PubMed ID: 4232015
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
    Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S
    Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of leishmaniasis.
    Balaña-Fouce R; Reguera RM; Cubría JC; Ordóñez D
    Gen Pharmacol; 1998 Apr; 30(4):435-43. PubMed ID: 9580315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
    Werbovetz K
    Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
    João A; Pereira MA; Cortes S; Santos-Gomes GM
    J Vet Med A Physiol Pathol Clin Med; 2006 Dec; 53(10):540-5. PubMed ID: 17105576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assays for evaluation of drug activity against Leishmania spp.
    Fumarola L; Spinelli R; Brandonisio O
    Res Microbiol; 2004 May; 155(4):224-30. PubMed ID: 15142618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
    Manna L; Reale S; Vitale F; Picillo E; Pavone LM; Gravino AE
    Vet J; 2008 Aug; 177(2):279-82. PubMed ID: 17553711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of leishmaniasis. Part V: Synthesis and in vitro bioevaluation of novel pyridinone derivatives.
    Pandey S; Suryawanshi SN; Nishi ; Goyal N; Gupta S
    Eur J Med Chem; 2007 May; 42(5):669-74. PubMed ID: 17306422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leishmaniasis in dogs in Germany: epidemiological case analysis and alternatives to conventional causal therapy].
    Gothe R; Nolte I; Kraft W
    Tierarztl Prax; 1997 Jan; 25(1):68-73. PubMed ID: 9157633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.